Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Alkermes (8AK) vs. Competitors

0 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:8AKAlkermesEUR 42.20EUR 7.04B15963.3351.80%Moderate BuyUnlock the DE:8AK analyst price target with TipRanks PremiumDE:8AKUnlock the DE:8AK top-analyst price target with TipRanks Premium
RDYDr Reddy's Laboratories$14.84$12.32B40.987.46%Moderate BuyUnlock the RDY analyst price target with TipRanks PremiumDE:8AK vs RDYUnlock the RDY top-analyst price target with TipRanks Premium
VTRSViatris$21.06$23.90B-39.7388.04%Moderate BuyUnlock the VTRS analyst price target with TipRanks PremiumDE:8AK vs VTRSUnlock the VTRS top-analyst price target with TipRanks Premium
SUPNSupernus$29.45$5.97B8.05-5.21%Strong BuyUnlock the SUPN analyst price target with TipRanks PremiumDE:8AK vs SUPNUnlock the SUPN top-analyst price target with TipRanks Premium
TAKTakeda Pharmaceutical Company$20.84$65.87B27.6648.75%Moderate BuyUnlock the TAK analyst price target with TipRanks PremiumDE:8AK vs TAKUnlock the TAK top-analyst price target with TipRanks Premium

Performance Comparison

-25%0%25%50%75%100%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:8AKAlkermes42.2015.4057.46%
RDYDr Reddy's Laboratories14.841.057.58%
VTRSViatris21.0610.5299.89%
SUPNSupernus29.456.3027.24%
TAKTakeda Pharmaceutical Company20.846.6046.35%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts